Director/Senior Director, Clinical Development

SystImmune is a leading and well‑funded clinical‑stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bispecific, multispecific antibodies, and antibody‑drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials, SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND‑enabling stages, representing cutting‑edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company’s success. SystImmune is seeking an experienced Director/Senior Director of Clinical Development to lead the direction, planning, execution, and interpretation of clinical trials within the Clinical Development program. This person would also collaborate across functions to deliver high‑quality clinical data that supports product development, regulatory submissions, and business strategy. Key Responsibilities Lead the design and implementation of clinical development programs grounded in sound medical and scientific principles, regulatory knowledge, and business objectives. Provide strategic medical input across the product lifecycle from early development through phase 3, for both internal and partnered programs. Oversee the execution and integrity of clinical trials. Collaborate with Clinical Operations to manage enrollment progress, timeline adherence, and delivery of key milestones. Proactively monitor trial safety in coordination with the Safety team, ensuring compliance with serious adverse event (SAE) reporting requirements. Drive the development and scientific accuracy of key clinical documents, including protocols, Investigator Brochures, Clinical Study Reports (CSRs), regulatory submissions, and response packages. Serve as the medical lead on clinical study teams, aligning medical strategy across functions. Act as a key clinical representative in regulatory interactions and ensure adherence to GCP, pharmacovigilance standards, SOPs, and global compliance requirements. Provide in‑house clinical expertise on assigned compounds and indications. Actively engage with investigators and opinion leaders to inform development strategy and protocol design. Stay current on therapeutic area developments through continuous learning and participation in scientific forums. Qualifications M.D. or equivalent (international degrees accepted). Minimum of 2 years of experience in medical monitoring of oncology clinical trials; phase 1/2 required, phase 3 experience preferred. Prior experience in clinical development or pharmaceutical/biotech settings. Proven track record in product safety oversight and clinical trial execution, particularly with biologics such as ADCs and immune‑oncology agents. Strong foundation in clinical and drug development processes. Sound medical judgment with expertise in medical safety data interpretation. Compensation and Benefits The expected base salary range for this position is $230,000 – $300,000 annually. Actual compensation will be based on a variety of factors, including but not limited to a candidate’s qualifications, experience, and skills. While most offers typically fall within the low to mid‑point of the range, we may extend an offer toward the higher end for exceptional candidates whose background and expertise exceeds the requirements of the role. We offer a comprehensive benefits package including 100% paid employee premiums for medical/dental/vision, supplemental STD and LTD coverage, a 401(k) plan with a 50% company match up to 3% and a vesting schedule of only 5 years, 15 PTO days per year, sick leave, and 11 paid holidays. SystImmune is an Equal Opportunity Employer. We welcome diverse talent and encourage all qualified applicants to apply. #J-18808-Ljbffr